Ardent Health Partners, LLC
ARDT · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $5,966,072 | $5,409,483 | $5,129,687 | $4,870,396 |
| % Growth | 10.3% | 5.5% | 5.3% | – |
| Cost of Goods Sold | $1,033,122 | $140,842 | $955,168 | $927,326 |
| Gross Profit | $4,932,950 | $5,268,641 | $4,174,519 | $3,943,070 |
| % Margin | 82.7% | 97.4% | 81.4% | 81% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3,884,681 | $3,607,656 | $3,371,680 | $3,132,330 |
| SG&A Expenses | $3,884,681 | $3,622,521 | $3,371,680 | $3,132,330 |
| Sales & Mktg Exp. | $0 | $14,865 | $0 | $0 |
| Other Operating Expenses | $642,507 | $1,416,616 | $585,811 | $374,178 |
| Operating Expenses | $4,527,188 | $5,039,137 | $3,957,491 | $3,506,508 |
| Operating Income | $405,762 | $229,504 | $217,028 | $436,562 |
| % Margin | 6.8% | 4.2% | 4.2% | 9% |
| Other Income/Exp. Net | -$42,702 | -$77,890 | $94,450 | -$140,675 |
| Pre-Tax Income | $363,060 | $151,614 | $311,478 | $295,887 |
| Tax Expense | $63,352 | $22,637 | $46,107 | $51,311 |
| Net Income | $210,343 | $50,292 | $188,909 | $154,258 |
| % Margin | 3.5% | 0.9% | 3.7% | 3.2% |
| EPS | 1.59 | 0.35 | 1.32 | 1.08 |
| % Growth | 354.3% | -73.5% | 22.2% | – |
| EPS Diluted | 1.58 | 0.35 | 1.32 | 1.08 |
| Weighted Avg Shares Out | 132,440 | 143,263 | 143,263 | 143,263 |
| Weighted Avg Shares Out Dil | 132,745 | 143,263 | 143,263 | 143,263 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $65,578 | $65,425 | $82,052 | $93,834 |
| Depreciation & Amortization | $146,288 | $140,842 | $138,173 | $137,204 |
| EBITDA | $574,926 | $349,996 | $531,703 | $526,925 |
| % Margin | 9.6% | 6.5% | 10.4% | 10.8% |